1. Home >
  2. M&A >
  3. Merger >
  4. United States >
  5. Massachusetts >
  6. Elicio Therapeutics Acquires Elicio Therapeutics

M&A Deal Summary

Elicio Therapeutics Acquires Elicio Therapeutics

On January 17, 2023, Elicio Therapeutics acquired life science company Elicio Therapeutics

Acquisition Highlights
  • This is Elicio Therapeutics’ 1st transaction in the Life Science sector.
  • This is Elicio Therapeutics’ 1st transaction in the United States.
  • This is Elicio Therapeutics’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2023-01-17
Target Elicio Therapeutics
Sector Life Science
Buyer(s) Elicio Therapeutics
Deal Type Merger

Target

Elicio Therapeutics

Boston, Massachusetts, United States
Elicio Therapeutic is a late-stage clinical company developing small molecules targeting acute organ injury and chronic fibrosis. Elicio Therapeutics was founded in 1998 and is based in Boston, Massachusetts.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Elicio Therapeutics

Boston, Massachusetts, United States
Category Company
Founded 2011
Sector Life Science
DESCRIPTION

Elicio Therapeutics is a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the treatment of cancer. Elicio Therapeutics was founded in 2011 and is based in Boston, Massachusetts.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal